Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.
Health Professionals
IMA203 Produces Responses in Heavily Pretreated Advanced Melanoma, Other Solid Tumors
The investigational PRAME-targeted T-cell therapy IMA203 generated responses in melanoma and other solid tumors,
RP1 Plus Nivolumab Is Active, Safe in Advanced Melanoma After Progression on Anti–PD-1 Therapy
RP1 plus nivolumab generated responses in advanced melanoma that progressed on or after prior anti–PD-1 therapy.
Novel Combo Shows Early Activity in PD-L1–Resistant NSCLC, Melanoma
Glycan editing of cell surface glycans with E-602 may represent a novel therapeutic approach among patients with cancer.